September, 2017 | The Wall Street Analyzer - Part 2

Latest News

[ February 2, 2023 ] XORTX Announces Submission of Orphan Drug Designation Request for XRx-008 Program to Treat Autosomal Dominant Kidney Disease News Feed
[ January 31, 2023 ] Zerify Starts The Year Off Strong News Feed
[ January 26, 2023 ] SCOTTIE RESOURCES INTERCEPTS 34.5 G/T GOLD OVER 4.7 METRES ON BLUEBERRY CONTACT ZONE News Feed
[ January 24, 2023 ] Zomedica to Participate in the Lytham Partners Investor Select Conference News Feed
[ January 23, 2023 ] XORTX Announces Positive Topline Results from XRX-OXY-101 Clinical Trial News Feed
[ January 18, 2023 ] Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies News Feed
[ January 17, 2023 ] SCOTTIE RESOURCES ANNOUNCES BOARD APPOINTMENT OF ELLIE OWENS News Feed

CEO Interviews

BIOCEPT, INC. (NASDAQ: BIOC) INTERVIEW WITH CEO MICHAEL NALL

September 6, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Michael Nall […]

No Picture

The Singing Machine Company, Inc. (OTCQX: SMDM) CEO Interview

September 6, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Gary Atkinson […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com